What is the upside for AstraZeneca's stock?
Their forecasts range from $54.00 to $73.00. On average, they anticipate AstraZeneca's share price to reach $63.50 in the next twelve months. This suggests a possible upside of 9.4% from the stock's current price. View analysts' price targets for AstraZeneca or view top-rated stocks among Wall Street analysts.
What are analysts'1-year price targets for AstraZeneca stock?
13 equities research analysts have issued 1-year price objectives for AstraZeneca's stock. Their forecasts range from $54. 00 to $73. 00. On average, they anticipate AstraZeneca's share price to reach $63. 50 in the next twelve months. This suggests a possible upside of 9. 4% from the stock's current price.
Is AstraZeneca a buy or sell?
The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom. Did nationalism spoil 'Britain's gift to the world'? - BBC News AstraZeneca has received a consensus rating of Buy. The company's average rating score is 2.77, and is based on 10 buy ratings, 3 hold ratings, and no sell ratings.
What does AstraZeneca plc do?
Sign-up to receive the latest news and ratings for AstraZeneca and its competitors with MarketBeat's FREE daily newsletter. AstraZeneca Plc is a holding company, which engages in the research, development, and manufacture of pharmaceutical products.
See more
Is AstraZeneca stock a buy now?
AstraZeneca has received a consensus rating of Buy. The company's average rating score is 2.67, and is based on 8 buy ratings, 4 hold ratings, and no sell ratings.
Is AstraZeneca a good stock to buy?
AstraZeneca is a fundamentally healthy stock. But does the valuation make it a buy? Investors can snatch up AstraZeneca's market-beating 2.3% dividend yield at a forward price-to-earnings (P/E) ratio of 13.3. This is only moderately higher than the drug manufacturer industry average of 11.3.
Is AstraZeneca a US stock?
AZN Stock Price | AstraZeneca PLC ADR Stock Quote (U.S.: Nasdaq) | MarketWatch.
What is the target price for AstraZeneca?
Stock Price Target AZNHigh$93.89Median$72.16Low$57.73Average$71.99Current Price$68.16
Is AZN overvalued?
Pharma company AstraZeneca (NASDAQ:AZN) has had a strong run of late, but I now consider it overvalued and would not be surprised to see a fallback in share price.
Will AZN go up?
AstraZeneca PLC (NASDAQ:AZN) The 23 analysts offering 12-month price forecasts for AstraZeneca PLC have a median target of 72.16, with a high estimate of 93.89 and a low estimate of 57.73. The median estimate represents a +9.69% increase from the last price of 65.78.
How often does AZN Pay Dividend?
There are typically 2 dividends per year (excluding specials), and the dividend cover is approximately 1.3.
Who owns AstraZeneca shares?
The company is a wholly owned subsidiary of AstraZeneca plc, a United Kingdom-based pharmaceutical company.
How many shareholders does AstraZeneca have?
The total number of shares in issue as at 31 December 2021 was 1,549,400,665. AstraZeneca PLC publishes its total number of voting rights each month. These notifications can be found in the Stock exchange announcements.
Why is AZN stock going up?
AstraZeneca raised its dividend for the first time in 10 years. AstraZeneca forecast higher 2022 sales after reporting a surge in revenue for the fourth quarter, boosted by sales of its Covid vaccine and the $39 billion acquisition of U.S. rare diseases drugmaker Alexion.
Should I buy or sell AstraZeneca stock right now?
12 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for AstraZeneca in the last year. There are currently 3 hol...
What is AstraZeneca's stock price forecast for 2022?
12 equities research analysts have issued twelve-month target prices for AstraZeneca's stock. Their forecasts range from $54.00 to $12,000.00. On a...
How has AstraZeneca's stock price performed in 2022?
AstraZeneca's stock was trading at $58.25 at the beginning of 2022. Since then, AZN shares have increased by 6.1% and is now trading at $61.79. Vi...
Are investors shorting AstraZeneca?
AstraZeneca saw a decrease in short interest in May. As of May 31st, there was short interest totaling 10,840,000 shares, a decrease of 34.0% from...
When is AstraZeneca's next earnings date?
AstraZeneca is scheduled to release its next quarterly earnings announcement on Thursday, August 4th 2022. View our earnings forecast for AstraZen...
How were AstraZeneca's earnings last quarter?
AstraZeneca PLC (NASDAQ:AZN) posted its earnings results on Friday, April, 29th. The company reported $0.95 earnings per share (EPS) for the quarte...
How often does AstraZeneca pay dividends? What is the dividend yield for AstraZeneca?
AstraZeneca announced a semi-annual dividend on Friday, February 11th. Shareholders of record on Friday, February 25th will be given a dividend of...
Is AstraZeneca a good dividend stock?
AstraZeneca(NASDAQ:AZN) pays an annual dividend of $1.93 per share and currently has a dividend yield of 3.12%. View AstraZeneca's dividend history .
When did AstraZeneca's stock split? How did AstraZeneca's stock split work?
Shares of AstraZeneca split on Monday, July 27th 2015. The 2-1 split was announced on Friday, June 26th 2015. The newly created shares were payable...
When did AstraZeneca announce its earnings?
When is AstraZeneca's dividend?
AstraZeneca PLC (NASDAQ:AZN) announced its quarterly earnings data on Thursday, April, 29th. The company reported $0.82 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $0.71 by $0.11.
What is the dividend yield of AstraZeneca?
AstraZeneca announced a semi-annual dividend on Friday, February 12th. Stockholders of record on Friday, February 26th will be paid a dividend of $0.95 per share on Monday, March 29th. This represents a dividend yield of 2.7%. The ex-dividend date is Thursday, February 25th.
When did AstraZeneca change its name?
AstraZeneca pays an annual dividend of $1.86 per share and currently has a dividend yield of 3.07%. The dividend payout ratio of AstraZeneca is 92.54%. Payout ratios above 75% are not desirable because they may not be sustainable.
What is AstraZeneca's specialty?
The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom. Read More.
What is AstraZeneca valuation?
AstraZeneca PLC discovers, develops, manufactures, and commercializes prescription medicines in the areas of oncology, cardiovascular, renal and metabolism, respiratory, infection, neuroscience, and gastroenterology worldwide. The company's marketed products include Tagrisso, Lynparza, Imfinzi, Enhertu, Koselugo, Lumoxiti, Equidacent, Zoladex, Faslodex, Iressa, Arimidex, Casodex/Cosudex, and others for oncology diseases; Onglyza, Bydureon, Lokelma, Byetta, Qtern, Symlin, and others for cardiovascular, renal, and metabolism diseases; and Symbicort, Pulmicort, Fasenra, Daliresp/Daxas, Duaklir, Tudorza/Eklira, Bevespi, Breztri, Anifrolumab, and others for respiratory and immunology diseases. It also offers other medicines and COVID-19 products, including Synagis, Fluenz Tetra/FluMist Quadrivalent, Seroquel IR/Seroquel XR, Vimovo, Movantik/Moventig, Nexium, Losec/Prilosec, and COVID-19 Vaccine AstraZeneca. The company serves primary care and specialty care physicians through distributors and local representative offices. It has a collaboration agreement with Daiichi Sankyo to develop and commercialize DS-1062 for the treatment of trophoblast cell-surface antigen 2 (TROP2) tumor; AliveCor, Inc. to develop non-invasive potassium monitoring solutions; Massachusetts General Hospital to accelerate digital health solutions; Sanguina on smartphone application study for hemoglobin management in patients with anemia of chronic kidney disease; Alchemab to enhance prostate cancer research; and Proteros biostructures GmbH to discover and develop novel small molecules for the treatment of various types of cancer. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.
Where is AstraZeneca headquarters?
A valuation method that multiplies the price of a company's stock by the total number of outstanding shares. AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England.
When was Zeneca founded?
AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England.
AstraZeneca Pharma - Announcement under Regulation 30 (LODR)-Newspaper Publication
The company was founded in 1999 through the merger of the Swedish Astra AB and the British Zeneca Group. Since the merger it has been among the world's largest pharmaceutical companies and has made numerous corporate acquisitions, including Cambridge Antibody Technology, MedImmune, Spirogen and Definiens.
AstraZeneca Pharma - Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company To Be Held On Tuesday, February 8, 2022
Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing a copy of newspa....
